Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline nebulization in primary ciliary dyskinesia
NL-OMON22149Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of sodium chloride and quinine in primary ciliary dyskinesia (PCD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in St. George's Respiratory Questionnaire total and sub-scores. Started Sep 2013; status: recruiting.
02
Drugs
sodium chloridequinine
03
Conditions
primary ciliary dyskinesia (PCD)
Beyond the preview
Go deeper on NL-OMON22149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22149.